{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-025172","form_type":"8-K","ticker":"HCTI","cik":"0001839285","company_name":"Healthcare Triangle, Inc.","filed_at":"2024-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.900737+00:00","generated_at":"2026-06-04T09:13:55.973229+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Healthcare Triangle receives Nasdaq delisting notice for insufficient stockholders' equity","bullets":["Stockholders' equity of $538,000 as of Dec 31, 2023, below Nasdaq's $2.5M minimum.","Nasdaq letter dated March 20, 2024; compliance plan due by May 6, 2024.","If plan accepted, company has until Sept 16, 2024 to regain compliance; risk of delisting.","Company intends to take all reasonable measures but no assurance of regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-025172","json":"https://secwatch.observer/filing/0001213900-24-025172.json","markdown":"https://secwatch.observer/filing/0001213900-24-025172.md","text":"https://secwatch.observer/filing/0001213900-24-025172.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1839285/000121390024025172/0001213900-24-025172-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1839285/000121390024025172/ea0202218-8k_healthcare.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T09:13:55.973229+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d73d2f0da9f22e7bdebd94e7c45841aee9db4f63","claim":"Healthcare Triangle, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"March 20, 2024, Healthcare Triangle, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Stock Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. In its annual report on Form 10-K for the period ended December 31, 2023, the Company reported stockholders’ equity of $538,000, and, as a result, does not currently satisfy Listing Rule 5550(b)(1). Nasdaq’s letter has no immediate impact on the listing of the","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1839285/000121390024025172/0001213900-24-025172-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}